4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001140361-23-010100
EVP, Head of R&D acquired 141,328 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Dupont Jakob · EVP, Head of R&D
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-03-01 | Grant or award : show line 1 in the form | +141,328 | 295,868 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-03-01 | Grant or award : show line 2 in the form Employee Stock Option (Right to Buy) | +317,987 | 317,987 | D |
Loading xslF345X03/form4.xml…